
EU Recommends Approval of Eylea™ 8 mg with Extended 6-Month Dosing Interval
Bayer’s Eylea™ 8 mg Receives EMA Recommendation for Extended 6-Month Dosing Interval in Europe Bayer has announced that the Eylea™ 8 mg Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive…